Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. (Q53915625)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

title

Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

main subject

teenager

1 reference

based on heuristic

inferred from title

author

Carolina Di Somma

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

Marco Salvatore

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

Annamaria Colao

series ordinal

1

object named as

A Colao

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

author name string

S Loche

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

A Di Sarno

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

M Klain

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

R Pivonello

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

M Pietrosante

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

G Lombardi

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

publication date

1 March 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

published in

Clinical Endocrinology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

volume

52

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

page(s)

319-327

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

cites work

Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Hyperprolactinemic anovulatory syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Growth-hormone and prolactin excess

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Treatment of prolactinomas.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Clinical aspects of growth hormone deficiency in adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

The Pathogenesis of Osteoporosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Reduced bone mineral density in patients with adult onset growth hormone deficiency.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Baseline measurement of bone mass predicts fracture in white women

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Genetic determinants of bone mass in adults. A twin study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

The diagnosis of growth hormone deficiency in children and adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

The Efficacy and Tolerability of CV 205–502 (a Nonergot Dopaminergic Drug) in Macroprolactinoma Patients and in Prolactinoma Patients Intolerant to Bromocriptine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Prediction of postmenopausal fracture risk with use of bone mineral measurements.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Comparison between Insulin-Induced Hypoglycemia and Growth Hormone (GH)-Releasing Hormone + Arginine as Provocative Tests for the Diagnosis of GH Deficiency in Adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Osteoporosis in men with hyperprolactinemic hypogonadism

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Diagnosis of growth-hormone deficiency in adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Decreased bone density in hyperprolactinemic women

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Long-term fracture prediction by bone mineral assessed at different skeletal sites

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Bone density in amenorrheic women with and without hyperprolactinemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Risk factors for spinal osteoporosis in men

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00902.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2265.2000.00902.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

PubMed publication ID

10718830

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10718830

retrieved

22 May 2018

reference URL

http://europepmc.org/abstract/MED/10718830

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53915625&oldid=1614360481"